ALGS
NASDAQ · Biotechnology
Aligos Therapeutics Inc
$5.54
+0.03 (+0.54%)
Open$5.38
Previous Close$5.51
Day High$5.54
Day Low$5.18
52W High$13.69
52W Low$3.98
Volume—
Avg Volume48.0K
Market Cap34.41M
P/E Ratio—
EPS$-7.31
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+11.7% upside
Current
$5.54
$5.54
Target
$6.19
$6.19
$4.22
$6.19 avg
$8.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.37M | 2.54M | 10.09M |
| Net Income | -15,146,114 | -25,262,236 | -1,613,644 |
| Profit Margin | -1,106.7% | -1,051.4% | -16.0% |
| EBITDA | -54,500,020 | -95,950,739 | -2,029,249 |
| Free Cash Flow | — | — | -1,586,727 |
| Rev Growth | -46.0% | -46.0% | -9.4% |
| Debt/Equity | 0.00 | 0.00 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |